BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2436281)

  • 1. Influence of the human pancreatic secretory trypsin inhibitor on trypsin-induced C3 and kininogen cleavage: an in vitro study.
    Ohlsson K
    Scand J Gastroenterol Suppl; 1986; 126():18-20. PubMed ID: 2436281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
    Lasson A; Ohlsson K
    Biochim Biophys Acta; 1982 Dec; 709(2):227-33. PubMed ID: 6185150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
    Lasson A; Dittmann B; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins.
    Håkansson HO; Ohlsson K
    Gastroenterol Jpn; 1992 Oct; 27(5):652-6. PubMed ID: 1358738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
    Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis.
    Balldin G; Eddeland A; Ohlsson K
    Scand J Gastroenterol; 1981; 16(5):603-9. PubMed ID: 6172839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease activation following reperfusion of porcine pancreatic allografts.
    Källén R; Montgomery A; Borgström A
    J Surg Res; 1992 Nov; 53(5):495-501. PubMed ID: 1279275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.
    Balldin G; Borgström A; Genell S; Ohlsson K
    Res Exp Med (Berl); 1983; 183(3):203-13. PubMed ID: 6196821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
    Balldin G; Borgström A; Marks WH; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):751-6. PubMed ID: 6207093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of canine pancreatic secretory trypsin inhibitor and interaction in vitro with complexes of trypsin-alpha-macroglobulin.
    Eddeland A; Ohlsson K
    Scand J Clin Lab Invest; 1976 Dec; 36(8):815-20. PubMed ID: 73214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers.
    Schmidtchen A
    Acta Derm Venereol; 2000 May; 80(3):179-84. PubMed ID: 10954207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cationic, pancreatic elastase in acute pancreatitis.
    Håkansson HO; Borgström A; Ohlsson K
    Scand J Clin Lab Invest; 1993 Feb; 53(1):17-24. PubMed ID: 7680823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxygen-derived free radicals in protease activation after pancreas transplantation in the pig.
    Petersson U; Källén R; Montgomery A; Borgström A
    Transplantation; 1998 Feb; 65(3):421-6. PubMed ID: 9484764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
    Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma alpha 2-macroglobulin-trypsin complexlike substance (MTLS) in pancreatic disease.
    Kato M; Hayakawa S; Naruse S; Kitagawa M; Nakae Y; Hayakawa T
    J Clin Lab Anal; 1996; 10(6):399-402. PubMed ID: 8951609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
    Marks WH; Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of alpha 2-macroglobulin-bound trypsin by soybean trypsin inhibitor.
    Bieth JG; Tourbez-Perrin M; Pochon F
    J Biol Chem; 1981 Aug; 256(15):7954-7. PubMed ID: 6167570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinin activation and protease inhibitors in acute pancreatitis in man.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1986; 198 Pt B():423-32. PubMed ID: 2433917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypsin-induced release of bradykinin and of C3 fragments in man: clinical and experimental studies on the protective role of alpha 2-macroglobulin and aprotinin.
    Ohlsson F; Balldin G; Lasson A
    Adv Exp Med Biol; 1983; 156 (Pt B)():1083-90. PubMed ID: 6190382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.